The latest update pegs Pacific Biosciences of California’s fair value at US$2.50 per share, compared with the prior US$2.42 anchor, giving investors a fresh reference point for the story. Analysts are ...
A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited ...
ArgenTag joins PacBio to enable instrument-free single-cell kits to support long-read isoform sequencing at single-cell ...
MENLO PARK, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate ...
ArgenTag have joined PacBio’s Compatible Partner Program and opened a grant to provide access to single-cell sequencing tech.
Pacific Biosciences’ fourth quarter results exceeded Wall Street’s expectations, supported by record consumables revenue and robust instrument placements, particularly for the Revio and Vega ...
AZoLifeSciences on MSN
Retrotransposons and their role in human genetic disorders
Retrotransposons are pivotal in human genome evolution, driving structural variation and regulatory innovation while influencing health and disease.
Increase in prevalence of genetic disorders, shift towards personalized medicine, and surge in demand for forensic DNA analysis are the major factors which drive the global genotyping market growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results